MMC Marsh & Mclennan Companies Inc

Price (delayed)

$205.98

Market cap

$101.27B

P/E Ratio

27.1

Dividend/share

$2.72

EPS

$7.6

Enterprise value

$102.56B

Marsh & McLennan Companies, Inc. is a global professional services firm, headquartered in New York City with businesses in insurance brokerage, risk management, reinsurance services, talent management, investment advisory, and ...

Highlights
Marsh & Mclennan Companies's EPS has increased by 24% YoY and by 8% QoQ
Marsh & Mclennan Companies's net income has increased by 23% YoY and by 8% QoQ
The price to earnings (P/E) is 2.5% lower than the 5-year quarterly average of 27.8 but 2.3% higher than the last 4 quarters average of 26.5
The debt has increased by 15% YoY

Key stats

What are the main financial stats of MMC
Market
Shares outstanding
491.66M
Market cap
$101.27B
Enterprise value
$102.56B
Valuations
Price to book (P/B)
8.33
Price to sales (P/S)
4.48
EV/EBIT
18.45
EV/EBITDA
15.64
EV/Sales
4.51
Earnings
Revenue
$22.74B
EBIT
$5.56B
EBITDA
$6.56B
Free cash flow
$3.84B
Per share
EPS
$7.6
Free cash flow per share
$7.78
Book value per share
$24.72
Revenue per share
$46.02
TBVPS
$57.02
Balance sheet
Total assets
$48.03B
Total liabilities
$35.66B
Debt
$15.44B
Equity
$12.19B
Working capital
$1.95B
Liquidity
Debt to equity
1.27
Current ratio
1.1
Quick ratio
1.04
Net debt/EBITDA
0.2
Margins
EBITDA margin
28.8%
Gross margin
100%
Net margin
16.5%
Operating margin
23.2%
Efficiency
Return on assets
8.5%
Return on equity
32.3%
Return on invested capital
44.5%
Return on capital employed
19.7%
Return on sales
24.4%
Dividend
Dividend yield
1.32%
DPS
$2.72
Payout ratio
35.8%

MMC stock price

How has the Marsh & Mclennan Companies stock price performed over time
Intraday
0.18%
1 week
0.27%
1 month
-0.05%
1 year
26.91%
YTD
8.71%
QTD
8.71%

Financial performance

How have Marsh & Mclennan Companies's revenue and profit performed over time
Revenue
$22.74B
Gross profit
$22.74B
Operating income
$5.28B
Net income
$3.76B
Gross margin
100%
Net margin
16.5%
Marsh & Mclennan Companies's net income has increased by 23% YoY and by 8% QoQ
MMC's operating income is up by 23% YoY and by 9% from the previous quarter
The net margin has increased by 12% YoY and by 6% from the previous quarter
The operating margin is up by 12% year-on-year and by 6% since the previous quarter

Growth

What is Marsh & Mclennan Companies's growth rate over time

Valuation

What is Marsh & Mclennan Companies stock price valuation
P/E
27.1
P/B
8.33
P/S
4.48
EV/EBIT
18.45
EV/EBITDA
15.64
EV/Sales
4.51
Marsh & Mclennan Companies's EPS has increased by 24% YoY and by 8% QoQ
The price to earnings (P/E) is 2.5% lower than the 5-year quarterly average of 27.8 but 2.3% higher than the last 4 quarters average of 26.5
The P/B is 16% more than the 5-year quarterly average of 7.2 and 7% more than the last 4 quarters average of 7.8
The equity has grown by 16% YoY and by 7% from the previous quarter
The P/S is 21% above the 5-year quarterly average of 3.7 and 9% above the last 4 quarters average of 4.1
The company's revenue rose by 10% YoY and by 2.4% QoQ

Efficiency

How efficient is Marsh & Mclennan Companies business performance
The company's return on invested capital has surged by 73% YoY and by 7% QoQ
Marsh & Mclennan Companies's return on sales has increased by 12% YoY and by 6% QoQ
The return on equity is up by 11% year-on-year and by 4.5% since the previous quarter
MMC's ROA is up by 6% since the previous quarter

Dividends

What is MMC's dividend history
DPS
$2.72
Dividend yield
1.32%
Payout ratio
35.8%
Recent dividends

Financial health

How did Marsh & Mclennan Companies financials performed over time
Marsh & Mclennan Companies's total assets is 35% higher than its total liabilities
Marsh & Mclennan Companies's total assets has increased by 9% YoY
The total liabilities is up by 7% year-on-year but it has declined by 2.1% since the previous quarter
The debt is 27% more than the equity
The equity has grown by 16% YoY and by 7% from the previous quarter
The debt has increased by 15% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.